Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.585 USD | +2.92% | -4.35% | +0.65% |
Apr. 30 | Leerink Partners Starts Lexicon Pharmaceuticals With Outperform Rating, $5 Price Target | MT |
Apr. 29 | Lexicon Pharmaceuticals' Chief Executive Lonnel Coats to Retire | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.65% | 379M | |
-3.46% | 102B | |
+1.41% | 96.09B | |
+2.13% | 22.28B | |
-15.84% | 21.4B | |
-9.28% | 18.14B | |
-39.98% | 17.02B | |
-14.65% | 16.09B | |
+4.39% | 13.83B | |
+31.35% | 11.97B |
- Stock Market
- Equities
- LXRX Stock
- News Lexicon Pharmaceuticals, Inc.
- Lexicon Pharmaceuticals Shares Rise After Piper Sandler Initiates Coverage